Skip to main content
. 2022 Feb 1;16(2):e0009926. doi: 10.1371/journal.pntd.0009926

Fig 2. Double reciprocal plots of initial velocity data in the presence of the dead-end inhibitor 9-deazaadenine.

Fig 2

(A) 9-deazaadenine is a competitive inhibitor vs. varied adenine (2.5–150 μM) at fixed apparent saturating concentrations of PRPP (1 mM) (B) 9-deazaadenine is an uncompetitive inhibitor vs. varied PRPP (12.5–1000 μM) at fixed apparent saturating concentrations of adenine (100 μM).

HHS Vulnerability Disclosure